Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Butler

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Pharmaceutical Biology|May 2, 2025
Medicinal plants of Sabah (North Borneo): lest we forgetCarynn Tanbuda, Mazdida Sulaiman, Pauline Yong Pau Lin, et al.
Journal of Medicinal Chemistry|November 24, 2018
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic ActivityAngie M Jarrad, Chee Wei Ang, Anjan Debnath, et al.
Pharmaceutical Biology|May 7, 2026
Medicinal food plants of Sabah (Eastern Malaysia): a source of potential natural products and nutraceuticals for the fight against cancerCarynn Tanbuda, Mazdida Sulaiman, Pauline Yong Pau Lin, et al.
International Journal of Antimicrobial Agents|June 24, 2020
Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.
Nature Communications|June 25, 2020
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteriaAlysha G Elliott, Johnny X Huang, Søren Neve, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
ACS Infectious Diseases|October 21, 2016
Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformansRoss D Blundell, Simon J Williams, Samantha D M Arras, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
ACS Infectious Diseases|April 9, 2021
Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing <i>Klebsiella pneumoniae</i> Is Predominately Driven by ChloramphenicolNusaibah Abdul Rahim, Yan Zhu, Soon-Ee Cheah, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Pharmaceutical Biology|May 2, 2025
Medicinal plants of Sabah (North Borneo): lest we forgetCarynn Tanbuda, Mazdida Sulaiman, Pauline Yong Pau Lin, et al.
Journal of Medicinal Chemistry|November 24, 2018
Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic ActivityAngie M Jarrad, Chee Wei Ang, Anjan Debnath, et al.
Pharmaceutical Biology|May 7, 2026
Medicinal food plants of Sabah (Eastern Malaysia): a source of potential natural products and nutraceuticals for the fight against cancerCarynn Tanbuda, Mazdida Sulaiman, Pauline Yong Pau Lin, et al.
International Journal of Antimicrobial Agents|June 24, 2020
Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicolNusaibah Abdul Rahim, Soon-Ee Cheah, Matthew D Johnson, et al.
Nature Communications|June 25, 2020
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteriaAlysha G Elliott, Johnny X Huang, Søren Neve, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2022
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is NeededMark S Butler, Valeria Gigante, Hatim Sati, et al.
ACS Infectious Diseases|October 21, 2016
Disruption of de Novo Adenosine Triphosphate (ATP) Biosynthesis Abolishes Virulence in Cryptococcus neoformansRoss D Blundell, Simon J Williams, Samantha D M Arras, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
ACS Infectious Diseases|April 9, 2021
Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing <i>Klebsiella pneumoniae</i> Is Predominately Driven by ChloramphenicolNusaibah Abdul Rahim, Yan Zhu, Soon-Ee Cheah, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Pageof 12